DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Vandazole is a drug marketed by Teva Pharms and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in VANDAZOLE is metronidazole. There are eighteen drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
A generic version of VANDAZOLE was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for VANDAZOLE
Pharmacology for VANDAZOLE
|Drug Class||Nitroimidazole Antimicrobial |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Teva Pharms||VANDAZOLE||metronidazole||GEL;VAGINAL||021806-001||May 20, 2005||BX||RX||No||No||Start Trial||Start Trial||Y||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|